✦ LIBER ✦

CYP3A4-mediated oxidation of lisofylline to lisofylline 4,5-diol in human liver microsomes

✍ Scribed by Hea Soon Shin; John T. Slattery

Book ID: 109388969
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 89 KB
Volume: 87
Category: Article
ISSN: 0022-3549
DOI: 10.1021/js970382f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enzymes in addition to CYP3A4 and 3A5 me

Enzymes in addition to CYP3A4 and 3A5 mediate N-demethylation of dextromethorphan in human liver microsomes

✍ Yi Wang; Jashvant D. Unadkat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Both indinavir and troleandomycin (CYP3A inhibitors) are incapable of completely inhibiting dextromethorphan metabolism to 3-methoxymorphinan in human liver microsomes. It is hypothesized that CYPs in addition to CYP3A4 and 3A5 contribute to this biotransformation. The effect of CYP-selective inhibi

Cytochrome P450 2C8 and CYP3A4/5 are inv

Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes

✍ Kyoung-Ah Kim; Ji-Young Park; Ji-Suk Lee; Sabina Lim 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 574 KB

Prediction of In Vivo Interaction Betwee

Prediction of In Vivo Interaction Between Triazolam and Erythromycin Based on In Vitro Studies Using Human Liver Microsomes and Recombinant Human CYP3A4

✍ Shin-ichi Kanamitsu; Kiyomi Ito; Carol E. Green; Charles A. Tyson; Noriaki Shima 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 489 KB

Validation of higher-throughput high-per

Validation of higher-throughput high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry assays to conduct cytochrome P450s CYP2D6 and CYP3A4 enzyme inhibition studies in human liver microsomes

✍ Inhou Chu; Leonard Favreau; Tony Soares; Chin-chung Lin; Amin A. Nomeir 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

In the early stage of drug discovery, thousands of new chemical entities (NCEs) may be screened before a single drug candidate can be identified for development. In order to accelerate the drug discovery process, we have developed higher-throughput enzyme assays to evaluate the inhibition of cytochr

Preclinical pharmacokinetics and metabol

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38α inhibitor: identification of an active metabolite in preclinical species and human liver microsomes

✍ Amit S. Kalgutkar; Heather L. Hatch; Frederick Kosea; Hang T. Nguyen; Edna F. Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 2 views